Your Messages Inbox
Your Article Summary
See Latest ArticlesFitch Raises Boston Scientifics Rating Outlook to Positive
Boston Scientific, 05/20/09
Boston Scientific Corporation announced that Fitch Ratings has raised the Company's rating outlook to positive from stable, while affirming the Company's corporate credit rating at BB+. The success the Company has had in stabilizing its drug-eluting stent business and returning its cardiac rhythm management business to growth, which has included the launch of a number of new DES and CRM products. Fitch noted that the Company's other businesses have been performing well.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Article Search
Sponsor